These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2987100)

  • 1. Tubular carcinoma of the breast. A long term follow-up.
    Carstens PH; Greenberg RA; Francis D; Lyon H
    Histopathology; 1985 Mar; 9(3):271-80. PubMed ID: 2987100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refined morphologic criteria for tubular carcinoma to retain its favorable outcome status in contemporary breast carcinoma patients.
    Goldstein NS; Kestin LL; Vicini FA
    Am J Clin Pathol; 2004 Nov; 122(5):728-39. PubMed ID: 15491969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the in situ component in 389 infiltrating ductal breast carcinomas.
    Carabias-Meseguer P; Zapardiel I; Cusidó-Gimferrer M; Godoy-Tundidor S; Tresserra-Casas F; Rodriguez-García I; Fábregas-Xauradó R; Xercavins-Montosa J
    Breast Cancer; 2013 Jul; 20(3):213-7. PubMed ID: 22271067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tubular carcinoma of the breast (clinico-morphological characteristics)].
    Frank GA; Volchenko NN
    Vopr Onkol; 1985; 31(5):15-21. PubMed ID: 2990106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubular carcinoma of the breast and associated intra-epithelial lesions: a comparative study with invasive low-grade ductal carcinomas.
    Fernández-Aguilar S; Simon P; Buxant F; Simonart T; Noël JC
    Virchows Arch; 2005 Oct; 447(4):683-7. PubMed ID: 16091953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of conservative therapy for invasive breast cancer by histologic subtype.
    Weiss MC; Fowble BL; Solin LJ; Yeh IT; Schultz DJ
    Int J Radiat Oncol Biol Phys; 1992; 23(5):941-7. PubMed ID: 1322387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive apocrine carcinoma of the breast: a long term follow-up study of 34 cases.
    d'Amore ES; Terrier-Lacombe MJ; Travagli JP; Friedman S; Contesso G
    Breast Cancer Res Treat; 1988 Sep; 12(1):37-44. PubMed ID: 2848603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphological diagnosis and prognosis in early ductal breast cancer].
    Frank GA; Volchenko NN
    Vopr Onkol; 1992; 38(3):299-310. PubMed ID: 1338666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinically impalpable mammary carcinoma: morphologic and histogenetic analysis. Apropos of 114 cases].
    Meynard P; Jacquemier J; Hans D; Ayme Y; Varette Y; Spitalier JM; Amalric R; Hassoun J
    Bull Cancer; 1989; 76(6):653-63. PubMed ID: 2550103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubular carcinoma of the breast.
    Cooper HS; Patchefsky AS; Krall RA
    Cancer; 1978 Nov; 42(5):2334-42. PubMed ID: 214219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Well-differentiated (tubular) carcinoma of the breast. A clinicopathologic study of 145 pure and mixed cases.
    Deos PH; Norris HJ
    Am J Clin Pathol; 1982 Jul; 78(1):1-7. PubMed ID: 6285690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinoma.
    Jorns JM; Thomas DG; Healy PN; Daignault S; Vickery TL; Snider JE; Mardis ER; Davies SR; Ellis MJ; Visscher DW
    Arch Pathol Lab Med; 2014 Nov; 138(11):1507-13. PubMed ID: 25357113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas.
    Domagala W; Lasota J; Dukowicz A; Markiewski M; Striker G; Weber K; Osborn M
    Am J Pathol; 1990 Dec; 137(6):1299-304. PubMed ID: 1701960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the clinicopathological characteristics and prognosis in 674 cases of breast intraductal papillary tumor].
    Wang WY; Wang X; Gao JD; Wang J; Liu JQ; Wang X; Zhao DB
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):429-433. PubMed ID: 28635232
    [No Abstract]   [Full Text] [Related]  

  • 15. Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion.
    Fang Y; Wu J; Wang W; Fei X; Zong Y; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
    Oncotarget; 2016 Sep; 7(39):64182-64190. PubMed ID: 27577080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal in situ component and prognosis in invasive mammary carcinoma.
    Millis RR; Ryder K; Fentiman IS
    Breast Cancer Res Treat; 2004 Mar; 84(2):197-8. PubMed ID: 15069931
    [No Abstract]   [Full Text] [Related]  

  • 17. Invasive tubular carcinoma of the breast frequently is clonally related to flat epithelial atypia and low-grade ductal carcinoma in situ.
    Aulmann S; Elsawaf Z; Penzel R; Schirmacher P; Sinn HP
    Am J Surg Pathol; 2009 Nov; 33(11):1646-53. PubMed ID: 19675453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic features associated with long-term survival in breast cancer.
    Dawson PJ; Karrison T; Ferguson DJ
    Hum Pathol; 1986 Oct; 17(10):1015-21. PubMed ID: 3019865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy.
    Vo T; Xing Y; Meric-Bernstam F; Mirza N; Vlastos G; Symmans WF; Perkins GH; Buchholz TA; Babiera GV; Kuerer HM; Bedrosian I; Akins JS; Hunt KK
    Am J Surg; 2007 Oct; 194(4):527-31. PubMed ID: 17826073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.
    de Mascarel I; MacGrogan G; Mathoulin-Pélissier S; Soubeyran I; Picot V; Coindre JM
    Cancer; 2002 Apr; 94(8):2134-42. PubMed ID: 12001109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.